Abbott Laboratories Share Price Wiener Boerse
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.88 EUR | +0.36% |
|
-0.31% | -26.50% |
| Market Cap | 15TCr 13TCr 12TCr 12TCr 22TCr 14,54800Cr 22TCr 1,44900Cr 56TCr 7,14000Cr 58TCr 57TCr 24,70000Cr | P/E 2026 * |
22.3x | P/E 2027 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 17TCr 14TCr 13TCr 12TCr 23TCr 15,65400Cr 23TCr 1,55900Cr 61TCr 7,68300Cr 62TCr 61TCr 26,57900Cr | EV / Sales 2026 * |
3.3x | EV / Sales 2027 * | 2.98x |
| Free-Float |
86.73% | Yield 2026 * |
2.88% | Yield 2027 * | 3.07% |
Last Transcript: Abbott Laboratories
| 1 day | +0.36% | ||
| 1 week | -0.31% | ||
| Current month | +6.10% | ||
| 1 month | +7.15% | ||
| 3 months | -19.37% | ||
| 6 months | -27.85% | ||
| Current year | -26.50% |
| 1 week | 75.92 |  | 78.1 |
| 1 month | 73.4 | | 79.48 |
| Current year | 70.1 | | 109.64 |
| 1 year | 70.1 | | 119.28 |
| 3 years | 70.1 | | 134.2 |
| 5 years | 70.1 | | 134.2 |
| 10 years | 49.6 | | 134.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | -0.31% | - | - | 16TCr | |
| -3.91% | -2.63% | -9.32% | -12.35% | 10TCr | |
| +2.53% | +10.41% | +65.18% | +62.25% | 5.64TCr | |
| -1.55% | -1.48% | -5.49% | +51.41% | 5.48TCr | |
| -2.45% | -4.18% | -16.67% | -45.25% | 4TCr | |
| -1.81% | -0.33% | - | - | 3.14TCr | |
| -2.64% | -4.73% | -12.95% | -45.25% | 2.82TCr | |
| -1.82% | -2.22% | +48.39% | -10.62% | 2.33TCr | |
| -0.33% | -1.13% | -14.90% | -4.83% | 2.04TCr | |
| -3.44% | -4.18% | -15.89% | -6.65% | 2.01TCr | |
| Average | -1.51% | -1.55% | +4.79% | -1.41% | 4.21TCr | |
| Weighted average by Cap. | -1.19% | -1.06% | +5.39% | +4.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.03TCr 4.34TCr 3.99TCr 3.75TCr 7.05TCr 4,74600Cr 7.11TCr 47TCr 18TCr 2,32900Cr 19TCr 18TCr 8,05800Cr | 5.48TCr 4.73TCr 4.35TCr 4.09TCr 7.69TCr 5,17100Cr 7.75TCr 52TCr 20TCr 2,53800Cr 21TCr 20TCr 8,78000Cr |
| Net income | 701.88Cr 605.51Cr 556.7Cr 523.98Cr 984.61Cr 66TCr 992.88Cr 6.6TCr 2.57TCr 33TCr 2.63TCr 2.58TCr 1,12500Cr | 839.23Cr 724.01Cr 665.64Cr 626.52Cr 1.18TCr 79TCr 1.19TCr 7.89TCr 3.07TCr 39TCr 3.15TCr 3.08TCr 1,34500Cr |
| Net Debt | 1.17TCr 1.01TCr 930.09Cr 875.43Cr 1.65TCr 1,10700Cr 1.66TCr 11TCr 4.29TCr 54TCr 4.4TCr 4.31TCr 1,87900Cr | 888.3Cr 766.33Cr 704.55Cr 663.15Cr 1.25TCr 84TCr 1.26TCr 8.35TCr 3.25TCr 41TCr 3.33TCr 3.26TCr 1,42300Cr |
| Date | Price | Change |
|---|---|---|
| 17/26/17 | 77.88 € | +0.36% |
| 16/26/16 | 77.60 € | +1.94% |
| 15/26/15 | 76.12 € | +0.26% |
| 12/26/12 | 75.92 € | -2.11% |
| 11/26/11 | 77.56 € | -0.72% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
